These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer. Seaberg RM; Eski S; Freeman JL Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356 [TBL] [Abstract][Full Text] [Related]
3. Management and outcome of recurrent well-differentiated thyroid carcinoma. Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757 [TBL] [Abstract][Full Text] [Related]
4. Treatment for microcarcinoma of the thyroid--clinical experience. Küçük NO; Tari P; Tokmak E; Aras G Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573 [TBL] [Abstract][Full Text] [Related]
5. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043 [TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Haq M; Harmer C Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067 [TBL] [Abstract][Full Text] [Related]
8. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome. Segal K; Shpitzer T; Hazan A; Bachar G; Marshak G; Popovtzer A Otolaryngol Head Neck Surg; 2006 May; 134(5):819-22. PubMed ID: 16647541 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224 [TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490 [TBL] [Abstract][Full Text] [Related]
12. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Shaha AR Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208 [TBL] [Abstract][Full Text] [Related]
13. Hurthle cell neoplasm of the thyroid gland. Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of insular versus papillary/follicular thyroid carcinoma. Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957 [TBL] [Abstract][Full Text] [Related]